渠桂荣

All filings by 渠桂荣 on record concern 拓新药业, in the capacity of board member. Over a trading history stretching from 29 November 2022 to 13 December 2022, the count stands at 3 filings.

On the market, this insider has only sold: 3 sales, €3.0M in total.

The latest filing, published on 13 December 2022, reports an open-market sale of €292k in 拓新药业. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.